Application 220788
- Type
- ANDA
- Sponsor
- ASPIRO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SODIUM BICARBONATE | SODIUM BICARBONATE | SOLUTION;INTRAVENOUS | 5MEQ/10ML (0.5MEQ/ML) | No | No |
| 002 | SODIUM BICARBONATE | SODIUM BICARBONATE | SOLUTION;INTRAVENOUS | 10MEQ/10ML (1MEQ/ML) | No | No |
| 003 | SODIUM BICARBONATE | SODIUM BICARBONATE | SOLUTION;INTRAVENOUS | 50MEQ/50ML (1MEQ/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220788-001 | SODIUM BICARBONATE | SODIUM BICARBONATE | 5MEQ/10ML (0.5MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | |
| A220788-002 | SODIUM BICARBONATE | SODIUM BICARBONATE | 10MEQ/10ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | |
| A220788-003 | SODIUM BICARBONATE | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220788-001 | AP |
| A220788-002 | AP |
| A220788-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220788-001 | SODIUM BICARBONATE | 5MEQ/10ML (0.5MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220788-002 | SODIUM BICARBONATE | 10MEQ/10ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220788-003 | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220788-001 | SODIUM BICARBONATE | 5MEQ/10ML (0.5MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220788-002 | SODIUM BICARBONATE | 10MEQ/10ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220788-003 | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220788-001 | SODIUM BICARBONATE | 5MEQ/10ML (0.5MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220788-002 | SODIUM BICARBONATE | 10MEQ/10ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220788-003 | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2026-04-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A220788-001 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220788-002 | AP | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220788-003 | AP | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220788-001 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220788-002 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220788-003 | AP | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220788-001 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220788-002 | AP | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220788-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | b620938d-ab2d-0934-e053-2a95a90a8483 | 2023-05-23 | Warnings, Adverse reactions | Sodium Bicarbonate SODIUM BICARBONATE |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | d1636b56-ad83-4439-e053-2a95a90a135e | 2023-05-02 | Warnings, Adverse reactions | Sodium Bicarbonate SODIUM BICARBONATE |
| Sodium Bicarbonate | SODIUM BICARBONATE | International Medication Systems, Limited | 77698221-a01d-4568-a7bc-d3d4e982875d | 2021-12-15 | Warnings, Adverse reactions | Sodium Bicarbonate SODIUM BICARBONATE |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | bfc9c321-665c-ca97-e053-2995a90a7954 | 2021-04-12 | Warnings, Adverse reactions | SODIUM BICARBONATE SODIUM BICARBONATE |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Aphena Pharma Solutions - Tennessee, LLC | 15605a6d-6c90-47d5-9d1f-f66a3f27d5fc | 2017-12-13 | Warnings | SODIUM BICARBONATE SODIUM BICARBONATE |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Richmond Pharmaceuticals, Inc. | e0b2f0d3-3849-4bdf-b3d4-e14e520e36ce | 2017-11-01 | Warnings | SODIUM BICARBONATE |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Richmond Pharmaceuticals, Inc. | fa10d93d-b3ed-4675-a117-f573d9e72bca | 2017-10-30 | Warnings | SODIUM BICARBONATE SODIUM BICARBONATE |
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | e9698a4f-1a95-4f28-a945-e8009d1d6dd4 | 2017-09-27 | Warnings, Adverse reactions | Sodium Bicarbonate SODIUM BICARBONATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.